SEC Form 4 · accession 0001022079-16-000253
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine T. Doherty
Officer — SVP, Clin. Franchise Solutions
Period of report
Apr 25, 2016
Accepted (ET)
Apr 27, 2016 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2016 | M | 23,667 | $51.20 | A | 106,285 | D | |
| Common StockF1 | Apr 25, 2016 | S | 23,667 | $74.459 | D | 82,618 | D | |
| Common StockF2 | Apr 25, 2016 | S | 5,883 | $74.40 | D | 76,735 | D | |
| Common StockF3 | holding | — | — | — | 4,155 | I | 401(k)/SDCP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F4 | $51.20 | Apr 25, 2016 | M | 23,667 | D | — | Feb 11, 2019 | Common Stock | 23,667 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $74.40 to $74.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $74.39 to $74.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F4The options vested in three annual installments beginning with the first on February 11, 2010, the second on February 11, 2011 and the final on February 11, 2012.